Apple has just received FDA approval to introduce sleep apnea detection on the upcoming Apple Watch Series 9, Series 10, and Watch Ultra 2, a key feature arriving just ahead of the Series 10’s release on September 20. The new functionality, which was first teased during last week’s iPhone 16 event, will roll out with watchOS 11, giving users an advanced way to track potential sleep apnea risks through their Apple Watch.
This feature works by collecting sleep data over 10 nights within a 30-day period. Using the watch’s built-in accelerometer, it monitors disturbances during sleep to assess whether users might be at risk for sleep apnea. However, Apple is careful to clarify that the tool isn’t meant to replace a formal diagnosis. Instead, it helps users recognize potential warning signs and encourages them to seek advice from healthcare professionals.
Sleep apnea, a condition where breathing repeatedly stops or becomes shallow during sleep, can lead to various health issues, including insomnia, daytime fatigue, headaches, and long-term complications. While Apple’s addition to its wearables is significant, it’s not the first company to venture into sleep apnea detection. Withings and Samsung have already secured FDA approval for similar features in their devices, positioning Apple alongside competitors in the growing field of health-focused wearables.
Despite this new feature, another health function — blood oxygen detection — remains disabled on Apple Watches in the U.S. due to an ongoing patent dispute. Still, Apple’s latest approval highlights its continued push to enhance user health monitoring, expanding the Watch’s role as a key player in personal wellness.
